Allostery Investments LP
CIK 1978599
13F portfolio (2025-Q2)
$8M
Positions
20
As reported on this filer's Form 13F for 2025-Q2, filed 2025-11-14. Long positions in SEC Section 13(f) securities; a lagged quarterly snapshot, filed up to 45 days after quarter-end. This filer has stopped filing 13F reports.
| 1 | ABVX | ABIVAX SA |
| 2 | AKRO | AKERO THERAPEUTICS INC |
| 3 | AMLX | AMYLYX PHARMACEUTICALS INC |
| 4 | CNTA | CENTESSA PHARMACEUTICALS PLC |
| 5 | EOLS | EVOLUS INC |
Top holdings — weights and history with Pro
This 13F filer is outside the free plan's window — the 50 largest filers by portfolio value plus our curated roster of managers. It is in neither group. Unlock everything with Pro — $29.99/moSee it live on AAPL →